MCID: RHN004
MIFTS: 61

Rhinitis

Categories: Respiratory diseases, Smell/Taste diseases

Aliases & Classifications for Rhinitis

MalaCards integrated aliases for Rhinitis:

Name: Rhinitis 12 29 55 44 15 73
Runny Nose 12 3

Classifications:



External Ids:

Disease Ontology 12 DOID:4483
MeSH 44 D012220
NCIt 50 C34986
SNOMED-CT 68 70076002
UMLS 73 C0035455

Summaries for Rhinitis

CDC : 3 Sore throat and runny nose are usually the first signs of a cold, followed by coughing and sneezing. Most people recover in about 7-10 days. You can help reduce your risk of getting a cold: wash your hands often, avoid close contact with sick people, and don’t touch your face with unwashed hands.

MalaCards based summary : Rhinitis, also known as runny nose, is related to ige responsiveness, atopic and pollen allergy, and has symptoms including nasal congestion (finding), posterior rhinorrhea and sneezing. An important gene associated with Rhinitis is IL13 (Interleukin 13), and among its related pathways/superpathways are Innate Immune System and PEDF Induced Signaling. The drugs Allegra and Allegra-D have been mentioned in the context of this disorder. Affiliated tissues include testes, skin and eye, and related phenotypes are growth/size/body region and hematopoietic system

Disease Ontology : 12 A upper respiratory infectious disease which involves irritation and inflammation of the mucous membrane of the nose due to viruses, bacteria or irritants. The inflammation results in generation of excessive amounts of mucus leading to runny nose, as well as nasal congestion and post-nasal drip.

Wikipedia : 76 Rhinitis, also known as coryza, is irritation and inflammation of the mucous membrane inside the nose.... more...

Related Diseases for Rhinitis

Diseases in the Rhinitis family:

Chronic Rhinitis

Diseases related to Rhinitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 254)
# Related Disease Score Top Affiliating Genes
1 ige responsiveness, atopic 32.7 IGHE IL13 IL4 IL4R IL5 RNASE3
2 pollen allergy 32.2 EPX ICAM1 IL13 IL4R IL5 RNASE3
3 giant papillary conjunctivitis 32.1 CCL11 CXCL8 IL4 RNASE3
4 common cold 31.5 CCL11 CCL5 CXCL8 ICAM1 IL13 IL5
5 allergic conjunctivitis 31.3 CCL11 CXCL8 HRH1 ICAM1 IL13 IL4
6 sinusitis 31.0 CXCL8 CYSLTR1 IL4R IL5 RNASE3
7 otitis media 31.0 CCL11 CXCL8 IGHE RNASE3
8 intrinsic asthma 30.8 IL4 IL5 RNASE3
9 allergic bronchopulmonary aspergillosis 30.8 EPX IL4 IL5
10 dermatitis 30.8 CCL11 IGHE IL13 IL4 IL5 RNASE3
11 pneumonia 30.7 CCL11 CCL5 CXCL8 IL13 IL5
12 bronchitis 30.7 CCL11 CXCL8 IL5 RNASE3
13 blepharoconjunctivitis 30.6 CCL11 IL4 RNASE3
14 food allergy 30.5 EPX IL13 IL4 IL5 RNASE3
15 vulvovaginitis 30.3 CCL11 CCL5 CXCL8
16 cough variant asthma 30.3 IL4 IL5 NGF RNASE3
17 chronic fatigue syndrome 30.1 CXCL8 NR3C1 POMC
18 lung disease 30.0 CCL5 CXCL8 IL13 IL5
19 conjunctivitis 29.7 CCL11 CXCL8 EPX ICAM1 IL13 IL4
20 pulmonary disease, chronic obstructive 29.6 CCL11 CCL5 CXCL8 IL13 NR3C1 RNASE3
21 allergic rhinitis 29.6 CCL11 CXCL8 EPX FOXJ1 HRH1 ICAM1
22 allergic asthma 29.3 CCL11 CCL5 CXCL8 EPX IGHE IL13
23 vernal keratoconjunctivitis 29.0 CCL11 CCL5 ICAM1 IL13 IL4 IL5
24 keratoconjunctivitis 28.7 CCL11 CXCL8 ICAM1 IL13 IL4 IL5
25 dermatitis, atopic 28.7 CCL11 CCL5 CXCL8 EPX HRH1 ICAM1
26 asthma 25.6 CCL11 CCL5 CXCL8 CYSLTR1 EPX HRH1
27 chronic rhinitis 12.5
28 vasomotor rhinitis 12.5
29 atrophic rhinitis 12.4
30 asthma-related traits 4 11.8
31 olfactory neuroblastoma 11.3
32 actinobacillosis 11.2
33 cytokine deficiency 11.0 IL13 IL5
34 loeffler endocarditis 11.0 IL5 RNASE3
35 angioimmunoblastic lymphadenopathy with dysproteinemia 11.0 IL13 IL5
36 pemphigoid gestationis 10.9 CCL11 IL5
37 paragonimiasis 10.9 IL13 IL5 RNASE3
38 prurigo nodularis 10.9 NGF RNASE3
39 strongyloidiasis 10.9 CCL11 IL13 IL5
40 penicillin allergy 10.9 IL13 IL4 IL4R
41 eosinophilic granuloma 10.9 EPX RNASE3
42 esophagitis, eosinophilic, 1 10.9 CCL11 IL13 IL5
43 bagassosis 10.9 CXCL8 IL5
44 night blindness, congenital stationary, type 1a 10.9 CCL11 IL13 IL5
45 beta-lactam allergy 10.9 IL13 IL4 IL4R
46 apple allergy 10.8 IL13 IL4 IL5
47 egg allergy 10.8 IGHE IL4 IL5
48 intestinal schistosomiasis 10.8 IL13 IL4 IL5
49 chronic tic disorder 10.8 IL13 IL4 IL5
50 asthma, nasal polyps, and aspirin intolerance 10.8

Graphical network of the top 20 diseases related to Rhinitis:



Diseases related to Rhinitis

Symptoms & Phenotypes for Rhinitis

UMLS symptoms related to Rhinitis:


nasal congestion (finding), posterior rhinorrhea, sneezing, sinus congestion, nasal irritation, rhinorrhea

MGI Mouse Phenotypes related to Rhinitis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 growth/size/body region MP:0005378 10.03 IL5 FOXJ1 KNG1 NGF HRH1 NR3C1
2 hematopoietic system MP:0005397 9.93 EPX HRH1 NR3C1 ICAM1 POMC IL13
3 digestive/alimentary MP:0005381 9.87 IL5 FOXJ1 NR3C1 ICAM1 IL13 IL4
4 immune system MP:0005387 9.77 HRH1 NR3C1 ICAM1 POMC IL13 VCAM1
5 respiratory system MP:0005388 9.23 FOXJ1 NR3C1 IL13 IL4 CCL11 IL4R

Drugs & Therapeutics for Rhinitis

FDA approved drugs:

(show all 18)
# Drug Name Active Ingredient(s) 18 Company Approval Date
1
Allegra 18 FEXOFENADINE HYDROCHLORIDE Hoechst Marion Roussel July 1996
2
Allegra-D 18 FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE Hoechst Marion Roussel March 1998
3
Astelin nasal spray 18 AZELASTINE HYDROCHLORIDE Wallace Laboratories November 1996
4
Atrovent 18 IPRATROPIUM BROMIDE Boehringer Ingelheim January 1996
5
Clarinex 18 DESLORATADINE Schering-Plough February 2002
6
Clemastine fumarate syrup 18 CLEMASTINE FUMARATE Morton Grove Pharmaceuticals March 1998
7
Dymista 18 AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE Meda Pharmaceuticals Inc May 2012
8
Flonase Nasal Spray 18 FLUTICASONE PROPIONATE GlaxoSmithKline November 1997
9
Grastek 18 Timothy Grass Pollen Allergen Extract Merck April 2014
10
Nasacort AQ Nasal Spray 18 TRIAMCINOLONE ACETONIDE Phone-Poulenc Rorer October 1997
11
Oralair 18 Greer Labs April 2014
12
Patanase 18 OLOPATADINE HYDROCHLORIDE Alcon April 2008
13
Qnasl 18 BECLOMETHASONE DIPROPIONATE Teva Pharmaceutical March 2012
14
Ragwitek 18 Merck April 2014
15
Rhinocort Aqua Nasal Spray 18 BUDESONIDE AstraZeneca October 1999
16
Tri-Nasal Spray 18 Muro Pharmaceutical February 2000
17
Xyzal 18 LEVOCETIRIZINE DIHYDROCHLORIDE UCB May 2007
18
Zyrtec 18 CETIRIZINE HYDROCHLORIDE Pfizer December 1995

Drugs for Rhinitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 512)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Lansoprazole Approved, Investigational Phase 4,Phase 3 103577-45-3 3883
2
Lidocaine Approved, Vet_approved Phase 4,Not Applicable 137-58-6 3676
3
Omalizumab Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 242138-07-4
4
Diazepam Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 2 439-14-5 3016
5
Levocetirizine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 130018-77-8 1549000
6
Cetirizine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83881-51-0 2678
7
Azelastine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 58581-89-8 2267
8
Ephedrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 299-42-3 9294
9
Pseudoephedrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 90-82-4 7028
10
Atracurium Approved, Experimental, Investigational Phase 4 64228-79-1 47319
11
Phenylephrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 59-42-7 6041
12
Ketamine Approved, Vet_approved Phase 4,Phase 1 6740-88-1 3821
13
Oseltamivir Approved Phase 4,Phase 3,Phase 1,Phase 2 204255-11-8, 196618-13-0 65028
14
Capsaicin Approved Phase 4,Phase 2,Phase 1,Not Applicable 404-86-4 1548943
15
Atropine Approved, Vet_approved Phase 4,Phase 2,Phase 1 5908-99-6, 51-55-8 174174
16
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
17
Nitric Oxide Approved Phase 4,Phase 2,Phase 1,Not Applicable 10102-43-9 145068 160954
18
Montelukast Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 158966-92-8 5281040
19
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2 50-24-8 5755
20
Desloratadine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 100643-71-8 124087
21
Acetaminophen Approved Phase 4,Phase 3 103-90-2 1983
22
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Phase 2 26787-78-0 33613
23
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
24
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 75614-87-8, 51-45-6 774
25
Oxymetazoline Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1491-59-4 4636
26
Betamethasone Approved, Vet_approved Phase 4,Phase 3 378-44-9 9782
27
Loratadine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 79794-75-5 3957
28
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 51-43-4 5816
29
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 3 437-38-7 3345
30
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2 83-43-2 6741
31
Dexlansoprazole Approved, Investigational Phase 4,Phase 3 138530-94-6, 103577-45-3 9578005
32
Fluticasone Approved, Experimental, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 90566-53-3 62924
33
Guaifenesin Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 93-14-1 3516
34
Xylometazoline Approved, Investigational Phase 4,Not Applicable 526-36-3 5709
35
Racepinephrine Approved Phase 4,Phase 3,Phase 2,Not Applicable 329-65-7 838
36
Rizatriptan Approved Phase 4 145202-66-0, 144034-80-0 5078
37
Menthol Approved Phase 4,Not Applicable 2216-51-5 16666
38
Doxazosin Approved Phase 4 74191-85-8 3157
39
Omeprazole Approved, Investigational, Vet_approved Phase 4 73590-58-6 4594
40
Budesonide Approved Phase 4,Phase 3,Phase 2,Not Applicable 51333-22-3 63006 5281004
41
Fluconazole Approved, Investigational Phase 4 86386-73-4 3365
42
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 1 22916-47-8 4189
43
Fexofenadine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 83799-24-0 3348
44
Theophylline Approved Phase 4,Phase 2 58-55-9 2153
45
Ciclesonide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 126544-47-6, 141845-82-1 444033
46
Triamcinolone Approved, Vet_approved Phase 4,Phase 3,Not Applicable 124-94-7 31307
47
Clotrimazole Approved, Vet_approved Phase 4 23593-75-1 2812
48
Mupirocin Approved, Investigational, Vet_approved Phase 4,Phase 3,Not Applicable 12650-69-0 446596
49
Prazosin Approved Phase 4 19216-56-9 4893
50
Ibuprofen Approved Phase 4,Phase 3,Phase 2,Phase 1 15687-27-1 3672

Interventional clinical trials:

(show top 50) (show all 1311)
# Name Status NCT ID Phase Drugs
1 Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis Unknown status NCT02014623 Phase 4 Control
2 Efficacy of Allergen Immunotherapy for Allergic Rhinitis in Thais Unknown status NCT01115595 Phase 4
3 The Relationship Between Gastroesophageal Reflux and Pediatric Rhinitis: Significance of Pale/Blue Colored Turbinate Unknown status NCT02278081 Phase 4 lansoprazole;placebo
4 Assessment of Sublingual Immunotherapy in Children Allergic to House Dust Mites Unknown status NCT01052610 Phase 4 sublingual house dust mites allergen extract;placebo in sublingual applicator
5 Comparative Study of Sinol and Sinol-M in Patients With Congestion Due to Allergic Rhinitis Unknown status NCT00825656 Phase 4 Sinol or Sinol-M nasal spray
6 Elaboration of Patient-friendly Treatment Strategy With Capsaicin Nasal Spray in Patients With Idiopathic Rhinitis Unknown status NCT02288156 Phase 4 Capsaicin;placebo
7 Evaluating Factors Involved in Dymista's Superior Clinical Efficacy to Fluticasone Propionate in the Treatment of Seasonal Allergic Rhinitis Unknown status NCT02402465 Phase 4 Placebo;Fluticasone propionate;Fluticasone/Azelastine nasal spray
8 Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation in Children With Allergic Rhinitis Unknown status NCT00488176 Phase 4 montelukast;cetirizine;montelukast and cetirizine;placebo
9 Singulair Use in Non-Allergic Rhinitis Eosinophil Syndrome (NARES) Unknown status NCT00406094 Phase 4 montelukast;placebo
10 AZELASTINE/FLUTICASONE (AZE/FLU) Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness in Allergic Rhinitis (AR) Unknown status NCT02238353 Phase 4 azelastine + fluticasone;Placebo
11 Cosalin® Monotherapy Versus Cosalin® and Xarlin® Combination Therapy Unknown status NCT01062139 Phase 4 Xarlin (Levocetirizine);Cosalin (Petasites hybridus CO2 extract)
12 4"S" - Seasonal Symptoms Suppression Study Unknown status NCT02557269 Phase 4 Xylometazoline - intranasal application;Azelastine - intranasal application;Mometasone furoate - intranasal application;Hydroxyl-propyl-methyl cellulose powder - intranasal application;Bilastine 20 mg;Prednisolone 5 mg
13 POLlinosis and Exhaled Breath Temperature Unknown status NCT01785394 Phase 4 5 grass allergen extract
14 The Comparison of Different Administration Routes of Pediatric Premedication Unknown status NCT02313337 Phase 4 Anesthesia induction(midazolam,fentanyl,propofol,atracurium);Anesthesia maintenance(midazolam,fentanyl,propofol,atracurium)
15 Comparison of Daily Mometasone Furoate Nasal Spray Alone Versus a Combination With Montelukast for Treatment of Chronic Rhinosinusitis With Asthma After Functional Endoscopic Sinus Surgery Unknown status NCT02110654 Phase 4 Montelukast;mometasone furoate nasal spray
16 Banlangen Granules Anti-seasonal Influenza Study Unknown status NCT02232945 Phase 4 placebo of oseltamivir phosphate;oseltamivir phosphate;Banlangen (Radix Isatidis) granules;placebo of Banlangen(Radix Isatidis) granules
17 Middle Meatal Bacteriology During Acute Respiratory Infection in Children Unknown status NCT00545961 Phase 4 placebo;amoxicillin clavulanate acid
18 Anti-inflammatory H1 Antihistamines Allergic Rhinitis Completed NCT02507635 Phase 4 Levocetirizine;Desloratadine
19 Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis Completed NCT01550471 Phase 4 Alvesco/Omnaris, QVAR/Beconase, Placebo/Placebo;Alvesco/Omnaris, Placebo/Placebo, QVAR/Beconase;QVAR/Beconase, Alvesco/Omnaris, Placebo/Placebo;QVAR/Beconase, Placebo/Placebo, Alvesco/Omnaris;Placebo/Placebo, Alvesco/Omnaris, QVAR/Beconase;Placebo/Placebo, QVAR/Beconase, Alvesco/Omnaris
20 Effectiveness of Oxymetazoline Added on Nasal Steroid in Rhinitis With Persistent Nasal Obstruction Completed NCT01847131 Phase 4 oxymetazoline;Placebo nasal spray
21 Quality of Life in Patients With Allergic Rhinitis: Clinical Trial With Bilastine or Loratadine Completed NCT02513290 Phase 4 Bilastine;Loratadine
22 Comparison of Effectiveness and Safety of Sublingual Immunotherapy in Children With Allergic Rhinitis Completed NCT00698594 Phase 4
23 Effectiveness Of Therapy With A Thermal Water Nasal Aerosol In Children With Seasonal Allergic Rhinitis Completed NCT01326247 Phase 4
24 Nasal Budesonide Efficacy on Nasal FeNO in Children With Allergic Rhinitis Completed NCT02409563 Phase 4 Budesonide nasal spray (100 mcg bid);Budesonide nasal spray (50 mcg bid
25 Montelukast and Fexofenadine Versus Montelukast and Levocetrizine Combination in Allergic Rhinitis Completed NCT02551536 Phase 4 Montelukast;Fexofenadine;Levocetrizine
26 Efficacy & Safety of Loratadine-Betamethasone Oral Solution for Treatment of Severe Perennial Allergic Rhinitis in Children (Study P03428) Completed NCT00963573 Phase 4 Loratadine;Betamethasone
27 Nebulized Beclometasone Dipropionate Improves Nasal Patency in Children With Allergic Rhinitis Completed NCT02646904 Phase 4 Nasal Beclomethasone Dipropionate;CERCHIO 10 mg/ml OS
28 Assessment of Intranasal Steroids in Allergic Rhinitis When Used Alone or in Combination With an Oral Antihistamine (Study P03270) Completed NCT00834119 Phase 4 Mometasone furoate;Mometasone furoate
29 Efficacy and Safety of Lectranal® in Treatment of Seasonal Allergic Rhinitis Symptoms Completed NCT00460538 Phase 4
30 A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis Completed NCT00609674 Phase 4 Fluticasone furoate nasal spray;Placebo
31 Efficacy and Tolerability of a Topical Microemulsion in Patients With Allergic Rhinitis Due to Sensitization to Pollen Completed NCT01478425 Phase 4
32 Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial Completed NCT00691665 Phase 4 Olopatadine HCL Nasal Spray, 0.6%;Fluticasone Propionate Nasal Spray, 50 mcg
33 Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367) Completed NCT00442559 Phase 4 montelukast sodium;inhaled corticosteroid
34 Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR) Completed NCT00449072 Phase 4 TAA-AQ, Nasacort® AQ;Claritin®
35 A Phase-IV, Open-label Study to Evaluate Safety/Tolerability of Once-daily AVAMYS (TM) Aqueous Nasal Spray 110mcg Among Vietnamese Adult Patients With Established Perennial Allergic Rhinitis Completed NCT01270958 Phase 4 Avamys aqueous nasal spray 110mcg
36 Levocetirizine 5 mg: Reduction of Symptoms, Airway Resistance and Sleep Impairment in Persistent Allergic Rhinitis Completed NCT00355771 Phase 4 Levocetirizine;Placebo
37 Allergic Rhinitis Changes the Sinus Microbiome Completed NCT01852513 Phase 4 QNASL;Placebo nasal spray
38 Effectiveness of Individualized Homeopathic Treatment in Perennial Allergic Rhinitis Completed NCT00822406 Phase 4 homeopathic medicine;placebo
39 The Efficacy and Safety of Hyeonggaeyeongyo-tang for Chronic Rhinitis According to Pattern Identification in Korean Medicine Completed NCT02477293 Phase 4 Hyeonggaeyeongyo-tang
40 Comparison of the Effects of Nasal Steroids and Montelukast on Olfactory Functions in Patients With Allergic Rhinitis Completed NCT02565212 Phase 4 Montelukast,mometazon froat
41 To Evaluate Adenosine Monophosphate and Allergen Challenge in Allergic Rhinitis Completed NCT00679250 Phase 4 levocetirizine;placebo to levocetirizine
42 A Clinical Study With Fluticasone Furoate Nasal Spray And Vehicle Placebo For The Treatment Of Perennial (Year-round) Allergic Rhinitis Completed NCT00682643 Phase 4 fluticasone furoate nasal spray;vehicle placebo nasal spray
43 Fluticasone and Salmeterol in Allergic Rhinitis Completed NCT01388595 Phase 4 FLUTICASONE PROPRIONATE;Salmeterol;PLACEBO
44 Alpha-Blockers in Allergic Rhinitis (MAN 01) Completed NCT01946035 Phase 4 Doxazosin XL
45 POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis) Completed NCT00160537 Phase 4 Levocetirizine
46 Effects of Hypertonic Saline Solution (NACL 3%+NAHCO3) on Nasal Inflammation in Children With AR. RinASol- Pilot Study Completed NCT02729012 Phase 4 hypertonic saline solution (NACL 3%+NAHCO3)
47 Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid o Completed NCT00806754 Phase 4 Ciclesonide nasal spray + placebo Azelastine;Ciclesonide nasal spray + Azelastine
48 Children, Perennial Allergic Rhinitis (PAR), l-t Growth Completed NCT00641212 Phase 4 Budesonide;Placebo
49 The Role of Montelukast in Rhinitis and Sleep Completed NCT00590772 Phase 4 montelukast;placebo
50 ATAREAL (Antihistamine Treatment for Allergic Rhinitis in Real Life) Completed NCT00160680 Phase 4 Levocetirizine

Search NIH Clinical Center for Rhinitis

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: rhinitis

Genetic Tests for Rhinitis

Genetic tests related to Rhinitis:

# Genetic test Affiliating Genes
1 Rhinitis 29

Anatomical Context for Rhinitis

MalaCards organs/tissues related to Rhinitis:

41
Testes, Skin, Eye, T Cells, Pituitary, Lung, Neutrophil

Publications for Rhinitis

Articles related to Rhinitis:

(show top 50) (show all 2903)
# Title Authors Year
1
Glucocorticoid-Induced Transcription Factor 1 (GLCCI1) Variant Impacts the Short-Term Response to Intranasal Corticosteroids in Chinese Han Patients with Seasonal Allergic Rhinitis. ( 29981236 )
2018
2
Local allergic rhinitis: Implications for management. ( 29900607 )
2018
3
Establishment of the Nasal Microbiota in the first 18 Months of Life - Correlation with Early Onset Rhinitis and Wheezing. ( 29452199 )
2018
4
SOCS3 Is Upregulated and Targeted by miR30a-5p in Allergic Rhinitis. ( 29471302 )
2018
5
Basophils from allergic rhinitis patients show allergen-specific upregulation of thymic stromal lymphopoietin receptor. ( 29413340 )
2018
6
Relationship Between Rhinitis, Asthma, and Eczema and the Presence of Sensitization in Young Swiss Adults. ( 29977657 )
2018
7
Induced pluripotent stem cell-derived mesenchymal stem cells activate quiescent T cells and elevate regulatory T cell response via NF-I_B in allergic rhinitis patients. ( 29921316 )
2018
8
A Randomized, Multicenter, Double-blind, Phase III Study to Evaluate the Efficacy on Allergic Rhinitis and Safety of a Combination Therapy of Montelukast and Levocetirizine in Patients With Asthma and Allergic Rhinitis. ( 29945738 )
2018
9
Reply to the letter to the author concerning: 'Does adenoid hypertrophy affect disease severity in children with allergic rhinitis?' ( 29423746 )
2018
10
Impact of acupuncture on antihistamine use in patients suffering seasonal allergic rhinitis: secondary analysis of results from a randomised controlled trial. ( 29440045 )
2018
11
Efficacy of indoor air purification in treating Artemisia (mugwort) pollen allergic rhinitis: study protocol for a randomised controlled trial. ( 29976165 )
2018
12
Effects of anti-allergic drugs on T cell-mediated nasal hyperresponsiveness in a murine model of allergic rhinitis. ( 29910099 )
2018
13
Gene and protein expression of <i>CXCR4</i> in adult and elderly patients with chronic rhinitis, pharyngitis or sinusitis undergoing thermal water nasal inhalations. ( 29497453 )
2018
14
Evaluation of carbopol as an adjuvant on the effectiveness of progressive atrophic rhinitis vaccine. ( 29909135 )
2018
15
The International Study of the Allergic Rhinitis Survey: outcomes from 4 geographical regions. ( 29423374 )
2018
16
Occupational allergic rhinitis and contact urticaria caused by Gum Arabic in a candy factory worker. ( 29446105 )
2018
17
Economic Burden of the Inadequate Management of Allergic Rhinitis and Urticaria in Asian Countries Based on the GAA^LEN Model. ( 29949833 )
2018
18
Allergic rhinitis management: what's next? ( 29406839 )
2018
19
Cold weather increases respiratory symptoms and functional disability especially among patients with asthma and allergic rhinitis. ( 29973669 )
2018
20
Comparison of Specific Immunoglobulin E with the Skin Prick Test in the Diagnosis of House Dust Mites and Cockroach Sensitization in Patients with Asthma and/or Allergic Rhinitis. ( 29950531 )
2018
21
Validation of the Children's Sleep Habits Questionnaire in a sample of Greek children with allergic rhinitis. ( 29338964 )
2018
22
Correlation between upper and lower airway inflammations in patients with combined allergic rhinitis and asthma syndrome: A comparison of patients initially presenting with allergic rhinitis and those initially presenting with asthma. ( 29434763 )
2018
23
Evaluation of allergic rhinitis with nasal symptoms and nasal mucociliary clearance in patients with fibromyalgia syndrome. ( 29889054 )
2018
24
Changes in basophil activation during immunotherapy with house dust mite and mugwort in patients with allergic rhinitis. ( 29423373 )
2018
25
Associations of TAP1 genetic polymorphisms with atopic diseases: asthma, rhinitis and dermatitis. ( 29416713 )
2018
26
The use of specific immunoglobulin E in nasal secretions for the diagnosis of allergic rhinitis. ( 29417583 )
2018
27
Surgical Management of Nonallergic Rhinitis. ( 29937065 )
2018
28
Radiological comparison of inferior turbinate hypertrophy between allergic and non-allergic rhinitis: does allergy really augment turbinate hypertrophy? ( 29417277 )
2018
29
Distinct Gene Expression Patterns between Nasal Mucosal Cells and Blood Collected from Allergic Rhinitis Sufferers. ( 29920501 )
2018
30
Long-term efficacy of standardised specific subcutaneous immunotherapy in children with persistent allergic rhinitis due to multiple allergens including house dust mites. ( 29374499 )
2018
31
Onset of action for loratadine tablets for the symptomatic control of seasonal allergic rhinitis in adults challenged with ragweed pollen in the Environmental Exposure Unit: a post hoc analysis of total symptom score. ( 29371864 )
2018
32
The asthma-rhinitis multimorbidity is associated with IgE polysensitization in adolescents and adults. ( 29331026 )
2018
33
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis. ( 29438602 )
2018
34
Otolaryngologist adherence to the AAO-HNSF Allergic Rhinitis Clinical Practice Guideline. ( 29412510 )
2018
35
Chinese Society of Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis. ( 29949830 )
2018
36
Use of the Control of Allergic Rhinitis and Asthma Test and pulmonary function tests to assess asthma control in pregnancy. ( 28749014 )
2018
37
Repeatability of nasal allergen challenge results - further validation of the allergic rhinitis clinical investigator collaborative (AR-CIC) protocols. ( 29432965 )